136 related articles for article (PubMed ID: 38414960)
1. Imaging features of breast cancer subtypes on contrast enhanced ultrasound: a feasibility study.
Chandola S; Dhamija E; Paul SB; Hari S; Batra A; Mathur S; Deo SVS
Ecancermedicalscience; 2023; 17():1619. PubMed ID: 38414960
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Enhanced Ultrasound and Conventional Ultrasound Characteristics of Breast Cancer With Different Molecular Subtypes.
Li X; Zhang J; Zhang G; Liu J; Tang C; Chen K; Chen P; Tan L; Guo Y
Clin Breast Cancer; 2024 Apr; 24(3):204-214. PubMed ID: 38102010
[TBL] [Abstract][Full Text] [Related]
3. Contrast-Enhanced Ultrasound Imaging of Breast Masses: Adjunct Tool to Decrease the Number of False-Positive Biopsy Results.
Lee SC; Tchelepi H; Grant E; Desai B; Luo C; Groshen S; Hovanessian-Larsen L
J Ultrasound Med; 2019 Sep; 38(9):2259-2273. PubMed ID: 30597640
[TBL] [Abstract][Full Text] [Related]
4. Association Between Contrast-Enhanced Ultrasound Characteristics and Molecular Subtypes of Breast Cancer.
Wen B; Kong W; Zhang Y; Xue H; Wu M; Wang F
J Ultrasound Med; 2022 Aug; 41(8):2019-2031. PubMed ID: 34837655
[TBL] [Abstract][Full Text] [Related]
5. Application of Contrast-Enhanced Ultrasound in the Differential Diagnosis of Different Molecular Subtypes of Breast Cancer.
Liang X; Li Z; Zhang L; Wang D; Tian J
Ultrason Imaging; 2020 Nov; 42(6):261-270. PubMed ID: 33019918
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound for the preoperative prediction of pathological characteristics in breast cancer.
Li LL; Su QL; Deng YX; Guo WW; Lun HM; Hu Q
Front Oncol; 2024; 14():1320714. PubMed ID: 38487727
[TBL] [Abstract][Full Text] [Related]
7. Multimodal ultrasound features of breast cancers: correlation with molecular subtypes.
Zhu JY; He HL; Jiang XC; Bao HW; Chen F
BMC Med Imaging; 2023 Apr; 23(1):57. PubMed ID: 37069528
[TBL] [Abstract][Full Text] [Related]
8. Application of Quantitative Parameters of Contrast-Enhanced Ultrasound in Common Benign and Malignant Lesions in Pediatric Livers: A Preliminary Study.
Han D; Wang T; Wang R; Chen J; Tang Y
Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998580
[TBL] [Abstract][Full Text] [Related]
9. Correlation study between the magnetic resonance imaging features of breast cancer and expression of immune molecular subtypes.
Long N; Ran C; Sun J; Hao CJ; Sui YB; Li J; Shi YX; Zou ZX; Qu YH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11518-11527. PubMed ID: 33275218
[TBL] [Abstract][Full Text] [Related]
10. Application of Contrast-Enhanced Ultrasound in the Diagnosis of Ductal Carcinoma In Situ: Analysis of 127 Cases.
Li W; Zhou Q; Xia S; Wu Y; Fei X; Wang Y; Tao L; Fan J; Zhou W
J Ultrasound Med; 2020 Jan; 39(1):39-50. PubMed ID: 31206200
[TBL] [Abstract][Full Text] [Related]
11. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
13. Role of contrast-enhanced ultrasound with time-intensity curve analysis for differentiating hypovascular solid pancreatic lesions.
Wang L; Nie F; Dong T; Li M; Li Y; Yin C
Eur Radiol; 2023 Jul; 33(7):4885-4894. PubMed ID: 36725721
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer.
Li N; Gong W; Xie Y; Sheng L
Breast; 2023 Dec; 72():103595. PubMed ID: 37925875
[TBL] [Abstract][Full Text] [Related]
15. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Qualitative and Quantitative Contrast-Enhanced Ultrasound for Pathological Subtypes of Small Solid Renal Masses.
He M; Gao Q; Xiang J; Mao Q; Jiang T
J Ultrasound Med; 2023 Aug; 42(8):1663-1673. PubMed ID: 36591796
[TBL] [Abstract][Full Text] [Related]
17. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasonographic findings of different histopathologic types of breast cancer.
Wang X; Xu P; Wang Y; Grant EG
Acta Radiol; 2011 Apr; 52(3):248-55. PubMed ID: 21498359
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
[TBL] [Abstract][Full Text] [Related]
20. Application of dynamic contrast enhanced ultrasound in distinguishing focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Qiu YJ; Zhao GC; Shi SN; Zuo D; Zhang Q; Dong Y; Lou WH; Wang WP
Clin Hemorheol Microcirc; 2022; 81(2):149-161. PubMed ID: 35253737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
